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ABSTRAK
Tujuan: untuk mengetahui insidens aritmia selama perawatan pada pasien sindrom koroner akut (SKA) 
dan untuk menilai pengaruh hiperglikemia admisi terhadap kejadian aritmia selama perawatan pasien SKA. 
Metode: studi kohort retrospektif ini menggunakan rekam medik pasien SKA yang dirawat di intensive coronary 
care unit (ICCU) RSUPN dr. Cipto Mangunkusumo (RSCM) antara 1 Januari-31 Desember 2014. Hiperglikemia 
admisi dinyatakan bila kadar gula darah admisi >140 mg/dL. Kejadian aritmia selama perawatan meliputi 
aritmia atrium, takikardia supraventrikel, blok AV derajat tinggi, dan aritmia ventrikel, yang diobservasi 
selama 7 hari perawatan. Hasil: Terdapat 232 subjek pada penelitian ini. Prevalensi hiperglikemia admisi 
sebesar 50,43%. Insidens aritmia selama perawatan adalah 21,55% (IK 95% 16,26-26,84). Analisis bivariat 
menunjukkan hiperglikemia admisi terkait dengan peningkatan risiko aritmia selama perawatan (RR 1,75; IK 
95% 1,04-2,93). Tidak terdapat hubungan antara jenis SKA, diabetes melitus (DM), obesitas, dan hipertensi 
dengan kejadian aritmia selama perawatan. Analisis multivariat menunjukkan OR hiperglikemia admisi setelah 
penyesuaian sebesar 2,85 (IK 95% 1,35-6,02), dengan variabel perancu DM. Kesimpulan: insidens aritmia 
selama perawatan pasien SKA pada penelitian ini adalah 21,55% (IK 95% 16,26-26,84). Hiperglikemia admisi 
dapat meningkatkan risiko kejadian aritmia selama perawatan pada pasien SKA.
Kata kunci: hiperglikemia admisi, kejadian aritmia selama perawatan, sindrom koroner akut.
ABSTRACT
Aim: to determine the incidence of in-hospital arrhythmias in patients with acute coronary syndrome (ACS) 
and to determine the influence of hyperglycemia at admission (HA) on in-hospital arrhythmias complicating ACS. 
Methods: a retrospective cohort study was conducted using secondary data from medical records of patients with 
ACS who were admitted to ICCU RSCM, between January 1st-December 31st, 2014. Hyperglycemia at admission 
was defined when the blood glucose level at admission was >140 mg/dL. The in-hospital arrhythmias encompassed 
atrial arrhythmia, supraventricular tacchycardia (SVT), high grade AV block (HAVB), and ventricular arrhythmia, 
during the first seven days of hospitalization. Results: there were 232 subjects in this study. The prevalence of HA 
was 50.43%. The incidence of in-hospital arrhythmia was 21.55% (95% CI 16.26-26.84). In bivariate analysis, 
there was significant association between HA and in-hospital arrhythmia (RR 1.75; 95% CI 1.04-2.93). There 
were no association between type of ACS, diabetes mellitus (DM), obesity, and hypertension, with the in-hospital 
arrhythmias. In multivariate analysis, the adjusted OR of HA was 2.85 (95% CI 1.35-6.02), and DM was the 
confounding variable. Conclusion: the incidence of in-hospital arrhythmias in patients with ACS was 21.55% (95% 
CI 16.26-26.84). Hyperglycemia at admission may increase the risk of in-hospital arrhythmia in patients with ACS.
Key words: hyperglycemia at admission; in-hospital arrhythmia; acute coronary syndrome.
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INTRODUCTION
Acute coronary syndrome (ACS) is still a 
major health problem worldwide.1 Furthermore, 
disease- and treatment-related complications 
affect the outcome. It is urgently needed 
to determine the early risk identification in 
reducing the morbidity and mortality.
Arrhythmia is a common complication 
in patients with ACS. It encompasses atrial 
arrhythmia, supraventricular tacchycardia (SVT), 
high grade AV block (HAVB), and ventricular 
arrhythmia.2-6 Yet, the incidence of in-hospital 
arrhythmia in patients with ACS in Indonesia is 
still unknown. Our preliminary study showed 
that in-hospital arrhythmia account for the most 
frequent complication.7
Hyperglycemia at admission is commonly 
found in patients with ACS, regardless the 
diabetes status. The prevalence of HA ranged 
from 25-50%. Martalena, et al.8 revealed that 
the proportion of hyperglycemia at admission 
(HA) in patients with ACS at the ICCU RSCM 
is 43.43%. The underlying mechanisms of HA 
can be direct due to increasing stress hormone 
and indirect due to acute or worsening insulin 
resistance.9 Hyperglycemia at admission is 
associated with increased risk of cardiogenic 
shock,10 re-infarction,11 urgent coronary artery 
bypass graft,12 and mortality.13 There have been 
two studies evaluating the relationship between 
HA and in-hospital arrhythmias.5,14 Yet, its causal 
relationship is unknown.
The ethnics are associated with differences 
in pattern of coronary heart disease-related 
risk factors, incidence, and complications.15 
Concerning the magnitude of problems, it 
urged us to conduct this study in Indonesia’s 
population. Related to glycometabolic response, 
it was reported that some variables have 
prognostic values in patients wtih ACS, such as 
fasting blood glucose,16 A1c,17 and mean average 
blood glucose during hospitalization.18 We used 
HA in this study because it is simple, rapid, 
available in all stages of health care, and routine 
laboratory examination in patients with ACS.
This study was aimed to determine the 
incidence of in-hospital arrhythmias in patients 
with ACS and to determine the influence of HA 
on in-hospital arrhythmias complicating ACS.
METHODS
The design of our study was retrospective 
cohort using secondary data from medical 
records. The subjects were patients with ACS 
who were admitted to ICCU RSCM, in the period 
between January 1st - December 31st 2014. The 
data collection was performed between October 
and November 2015. The inclusion criteria was 
patients with ACS. The exclusion criteria were 
incomplete data, hypoglycemia at admission 
(<70 mg/dL),19 arrhythmia at admission, and 
severe left ventricular dysfunction.
The blood glucose samples were collected 
within one hour of admission. Blood sugar 
level was measured using ABX Pentra® 
machine. Hyperglycemia at admission was 
defined as blood glucose level at admission 
>140 mg/dL.19 In-hospital arrhythmias 
encompassed atrial arrhythmia, SVT, HAVB, 
and ventricular arrhythmia in the first seven days 
of hospitalization through ECG interpretation 
or events reported in medical record.20 The 
confounding variables were type of ACS, 
obesity, DM, and hypertension.
Data analysis was performed using SPSS 
version 20. The chi-square test was performed on 
bivariate analysis. The effect was evaluated and 
expressed as relative risk (RR). The multivariate 
analysis was performed using logistic regression 
test. The effect was evaluated and expressed as 
adjusted odds ratio (OR). 
This study had been approved by the Ethical 
Committee, Faculty of Medicine, Universitas 
Indonesia, by the registration number 917/UN2.
F1/ETIK/ 2015 on October 19th, 2015.
RESULTS
During the study, there were 332 patients 
admitted to ICCU RSCM and 284 patients 
(85.54%) were diagnosed as ACS. As many 52 
out of 284 patients were excluded due to two 
patients with incomplete data, 20 patients with 
arrhythmia at admission, 29 patients with severe 
left ventricular dysfunction, and one patient with 
hypoglycemia at admission.
There were 232 subjects in this study. The 
prevalence of HA in this study was 50.43%. The 
incidence of in-hospital arrhythmias was 21.55% 
(95% CI 16.26-26.84), consisted of atrial 
Vol 47 • Number 4 • October 2015              The influence of hyperglycemia at admission on in-hospital arrhytmias
293
arrhythmia (9.48%), ventricular arrhythmia 
(7.75%), HAVB (3.45%), and SVT (0.86%) 
(Table 1).
Based on bivariate analysis, there was 
significant association between HA and in-
hospital arrhythmias (RR 1.75; 95% CI 1.04-
2.93). There were no relationship between 
in-hospital arrhythmias and type of ACS 
(p=0.36), DM (p=0.36), obesity (p=0.73), and 
hypertension (p=0.54).
Based on multivariate analysis, we found 
that the adjusted OR for HA was 2.85 (95% 
CI 1.35-6.02) and DM was the confounding 
variable associated with the influence of HA on 
in-hospital arrhythmias (Table 2).
Table 1. Baseline characteristics of the subjects (N= 232)
Variables HA group (n=117) Non-HA group (n=115) 
Sex (male), n (%) 76 (64.96) 77 (66.96)
Age (year), mean (SD)  60.42 (10.48) 60.44 (11.10)
Length of hospitalization (day), mean (SD) 8.07 (3.89) 7.43 (3.40)
Risk factor, n (%)
 - Hypertension 83 (70.94) 71 (61.74)
 - Smoking 55 (47.01) 52 (45.22)
 - Diabetes Mellitus 70 (59.83) 17 (14.78)
 - Dyslipidemia 60 (51.28) 57 (49.56)
 - CHD 35 (29.91) 27 (23.48)
 - Chronic kidney disease 32 (27.35) 26 (22.61)
 - Obesity 47 (40.17) 41 (35.65)
Left ventricular ejection fraction, n (%)
 - Hyperdinamic 11 (9.41) 18 (15.65)
 - Normal 65 (55.55)  66 (57.39)
 - Mild dysfunction  25 (21.37)  22 (19.13)
 - Moderate dysfunction  16 (13.67)  9 (7.83)
Type of ACS, n (%)
 - STEMI 33 (28.20) 25 (21.74)
 - NSTEMI 52 (44.44) 33 (28.7)
 - UAP 32 (27.35) 57 (49.56)
In-hospital arrhythmias, n (%) 32 (27.35) 18 (15.65)
Type of arrhythmia, n (%)
 - Atrial aritmia 12 (37.50) 10 (55.55)
 - SVT 2 (6.25) 0 (0)
 - Ventricular arrhythmia 13 (40.62) 5 (27.78)
 - HAVB 5 (15.62) 3 (16.67)
Time of the event, n (%)
 - Day 1 16 (13.70) 7 (6.1)
 - Day 2 9 (7.70) 5 (4.3)
 - Day 3 4 (3.40) 2 (1.7)
 - Day 4 2 (1.70) 1 (0.9)
 - Day 5 1 (0.90) 0 (0)
 - Day 6 0 (0.00) 1 (0.9)
 - Day 7 0 (0.00) 2 (1.7)
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DISCUSSION
Sanjuan, et al.5 revealed that HA was 
associated with increased risk of in-hospital 
ventricular arrhythmia. Koracevic, et al.14 
reported that atrial fibrilllation (AF) was more 
common in the HA group, compared to non-
HA group. Yet, they did not evaluate a casual 
relationship. This is the first study that evaluates 
a causal relationship between HA and in-hospital 
arrhythmias using cohort design. Arrhythmia at 
admission was excluded.
This study involved 232 subjects. Most 
of the subjects were male (68.28%), which is 
consistent with previous studies.21,22 Mean age of 
subjects was 60.42 (SD 10.48) years old  in HA 
group and 60.44 (SD 11.10) years old  in non-
HA group. Some studies reported the same range 
of mean age of subjects.21,22 The old age is one 
of important risk factors in ACS and associated 
with physiological changes and comorbidities 
resulted poor prognosis.23
We found in this study that the prevalence 
of HA was 50.43%. Sanjuan, et al.5 in Spain 
reported that the proportion of HA was 54.00%, 
while Ayhan, et al.24 in Turkey showed that the 
proportion of HA was 48.3%, and Mansour, 
et al.21 revealed that the prevalence of HA in 
Southern Iraq was 61.70%. These different 
prevalences reported may be due to the different 
cut-off value of HA and the sampling method 
conducted in the studies. Besides, the ethnics 
seemed to influence the prevalence of HA.
The incidence of in-hospital arrhythmia in 
this study was 21.55%. Based on the type of 
arrhythmias, the incidence of atrial arrhythmia 
was 9.48%, SVT was 9.86%, ventricular 
arrhythmia was 7.75%, and HAVB was 3.45%. 
The incidence of atrial arrhythmia in this study 
differs with Jabre, et al.25 (6.77%) and Almendro-
Delia, et al.26 (4.00%), due to different duration 
of observation and sampling method used in 
the studies. The incidence of SVT in this study 
differs with Winkler, et al.27 (13.30%), due to 
different duration of observation and tools used 
in identifying the arrhythmias. The incidence 
of ventricular arrhythmia in this study differs 
with Hersi, et al.28 (4.20%) and Sanjuan, et al.5 
(20.00%), due to different exclusion criteria 
and sampling method used among studies. The 
incidence of HAVB in this study differs with 
Singh, et al.29 (2.90%), due to different exclusion 
criteria used in the studies.
The Relationship between HA and in-hospital 
Arrhythmia in Patients with ACS
We found that HA was associated with in-
hospital arrhythmias in patients with ACS (RR 
1.75; 95% CI 1.04-2.93). It is consistent with the 
previous studies. Koracevic, et al.14 reported that 
AF was more often in HA group significantly, 
compared to non-HA group (OR 2.07; 95% CI 
1.18-3.64). Sanjuan, et al.5 revealed that HA 
was associated with ventricular arrhythmia 
(OR 1.5; 95% CI 1.04-2.30). The underlying 
mechanisms of this association can be explained 
in several pathways. First, insulin resistance and 
acute hyperglycemia increase free fatty acid 
concentration and affect sympatho-vagal nerve 
imbalance.9,30 The lipid accumulation in myocard 
causes calcium overload, while sympatho-vagal 
nerve imbalance causes prolonged QT interval. 
Second, insulin resistance and hyperglycemia 
inflammation increases in ACS, contributing 
to both structural and electrical remodeling.31 
Third, hyperglycemia increases free radical 
production and decreases nitric oxide (NO) 
production, resulting prolongation of myocardial 
repolarization, tacchycardia potentiation, 
decelerated protection from ventricular 
arrhythmia, and sympathetic modulation of 
ventricular electrophysiological properties.30 
Fourth, hyperglicemia activates intracrin renin-
angiotensin system resulting disturbances 
in permeability of gap junction, it affects 
myocardial dysfunction and arrhythmia.32 Fifth, 
hyperglycemia increases platelet aggregation 
causing further processess, including action 
Table 2. Multivariate analysis of HA, confounding 
variables, and in-hospital arrhythmias
P OR (95% CI) ∆ OR (%)
Crude OR
HA 0.03 2.03 (1.06-3.87) -
Adjusted OR
 - Type of ACS 0.04 1.99 (1.04-3.82) 1.67
 - DM 0.01 2.86 (1.36-6.02) 43.41
 - Hypertension 0.01 2.82 (1.34-5.94) 1.36
 - Obesity 0.01 2.85 (1.35-6.02) 1.06
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potential changes, changes in myocardial 
contractility, and action potential dispersion.33
The Relationship between the Confounding 
Variables, HA, and the in-hospital Arrhythmia 
in Patients with ACS
There were some factors considered as 
confounding variables in this study based on 
biological mechanisms, which were type of ACS, 
DM, hypertension, and obesity. Although none 
of them were statistically significant (p<0.25) on 
bivariate analysis, we proceeded the multivariate 
analysis based on clinically-importance basis. 
The multivariate analysis showed that DM is 
confounding variable in the influence of HA on in-
hospital arrhythmia in patients with ACS. It might 
be due to poor DM status, as shown by Dublin, 
et al.34 There are some other mechanisms relating 
to DM and arrhythmia, including deteriorating 
inflammation in DM worsens myocardial 
fibrosis and diastolic dysfunction,35 DM is 
related to left atrial dilation and is associated 
with reentrant electric circuit propagation,36 
and DM is associated with parasympathetic and 
heterogenous sympathetic denervation.37
The Causal Relationship between HA and 
in-hospital Arrhythmias
We propose a causal relationship between 
HA and in-hospital arrhythmias. First, we 
proposed that HA was associated with the in-
hospital arrhythmias, because we found that 
only HA got p<0.05 on bivariate analysis. 
Second, our study result were consistent with 
previous studies, Sanjuan, et al.5 and Koracevic, 
et al.14 Third, this study specifically defined 
in-hospital arrhythmias as the outcome, while 
arrhythmia at admission was excluded. Fourth, 
this study used cohort design and excluded 
arrhythmia at admission. We proposed that HA 
(the cause) preceeded the in-hospital arrhythmias 
(the event). Fifth, there are some underlying 
mechanisms revealing biological plaucibility 
between HA and in-hospital arrhythmias, 
including increasing FFA concentration and 
sympatho-vagal nerve imbalance, deteriorating 
inflammation, increasing free radicals production 
and decreasing NO production, inducing intracrin 
renin-angiotensin system, and increasing platelet 
aggregation.9,31-34
Limitation of the Study
This was a retrospective cohort study. It 
might limit the completeness of supporting data 
related to risk factors, ECGS, or event reporting.
Despite some limitations, this study may 
provide good evidence to increase physicians’ 
awareness of HA and higher risk of in-hospital 
arrhythmias in patients with ACS.
CONCLUSION
The incidence of in-hospital arrhythmias 
in patients with ACS was 21.55% (95% CI 
16.26-26.84). Hyperglycemia at admission may 
increase the risk of in-hospital arrhythmias. 
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